- Catalent, Inc.

QQQ $ 633.20 nm (nm)

DIA $ 475.83 $ -1.36 (-0.29 %)

SPY $ 684.43 nm (nm)

TLT $ 90.42 nm (nm)

GLD $ 371.67 $ 7.13 (1.96 %)

Previous Close

$ 63.48

Open

Bid

-- x --

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 41.15 - $ 63.50

Volume

13,882,060

Average Volume

Market Cap

11.52B

Beta (5Y Monthly)

$ 1.22

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-05-2024	09-30-2024	10-Q
2	09-06-2024	06-30-2024	10-K
3	05-08-2024	03-31-2024	10-Q
4	02-14-2024	12-31-2023	10-Q
5	12-08-2023	06-30-2023	10-K
6	12-08-2023	09-30-2023	10-Q
7	06-12-2023	03-31-2023	10-Q
8	02-07-2023	12-31-2022	10-Q
9	11-01-2022	09-30-2022	10-Q
10	08-29-2022	06-30-2022	10-K
11	05-03-2022	03-31-2022	10-Q
12	02-01-2022	12-31-2021	10-Q
13	11-02-2021	09-30-2021	10-Q
14	08-30-2021	06-30-2021	10-K
15	05-04-2021	03-31-2021	10-Q
16	02-02-2021	12-31-2020	10-Q
17	11-03-2020	09-30-2020	10-Q
18	08-31-2020	06-30-2020	10-K
19	05-05-2020	03-31-2020	10-Q
20	02-03-2020	12-31-2019	10-Q
21	11-05-2019	09-30-2019	10-Q
22	08-27-2019	06-30-2019	10-K
23	05-07-2019	03-31-2019	10-Q
24	02-05-2019	12-31-2018	10-Q
25	11-06-2018	09-30-2018	10-Q
26	08-28-2018	06-30-2018	10-K
27	05-01-2018	03-31-2018	10-Q
28	02-05-2018	12-31-2017	10-Q
29	11-06-2017	09-30-2017	10-Q
30	08-28-2017	06-30-2017	10-K
31	05-04-2017	03-31-2017	10-Q
32	02-06-2017	12-31-2016	10-Q
33	11-07-2016	09-30-2016	10-Q
34	08-29-2016	06-30-2016	10-K
35	05-04-2016	03-31-2016	10-Q
36	02-09-2016	12-31-2015	10-Q
37	11-03-2015	09-30-2015	10-Q
38	09-02-2015	06-30-2015	10-K
39	05-05-2015	03-31-2015	10-Q
40	02-12-2015	12-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

FDA Flags Alarming Contamination At Novo N...
08/25/2025 17:59:39

Novo Nordisk's acquired facility faces scrutiny over recurring contamination, incomplete investigations, and ineffective co...

Lennox To Replace Catalent In S&P 500, Eff...
12/18/2024 22:29:19

ozempic-maker-novo-nordisk-invests-over-1-billion-in-new-denmark-production-facility-closer-to-add-3-more-from-catalent

Ozempic Maker Novo Nordisk Invests Over $1...
12/16/2024 13:32:08

Novo Nordisk unveils a $1.2 billion production facility in Denmark and finalizes Catalent acquisition, with financial and opera...

EU Regulators Say Novo Holdings Secures Un...
12/06/2024 18:06:00

- Reuters

EU Antitrust Regulators Expected to Approv...
11/22/2024 17:43:18

- Reuters

Catalent Q1 2025 Adj EPS $(0.13) May Not B...
11/05/2024 12:03:43

Catalent (NYSE:CTLT) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $0.05 by 360...

roches-q3-sales-surge-led-by-ocrevus-vabysmo-urges-regulators-to-block-novo-holdings-165b-catalent-acquisition

Roche's Q3 Sales Surge Led By Ocrevus, Vab...
10/23/2024 23:05:27

Roche reported a 9% increase in third-quarter sales, driven by strong performance from Ocrevus and Vabysmo. Roche also raised c...

Catalent's CEO Confirms Leadership Continu...
10/21/2024 11:03:09

Catalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, toda...

after-us-senator-unions-urge-federal-trade-commission-to-block-novos-165b-acquisition-of-catalent

After US Senator, Unions Urge Federal Trad...
10/18/2024 18:39:32

Public interest groups are urging the FTC to block Novo Holdings' $16.5 billion acquisition of Catalent, citing concerns ov...

jim-cramer-we-need-more-uranium-recommends-this-stock-says-novo-nordisk-doesnt-hold-a-candle-to-big-pharma-rival

Jim Cramer: 'We Need More Uranium,' Recomm...
10/15/2024 12:22:07

Jim Cramer believes Uranium Energy Corp. is going higher, thanks to a recent acquisition deal. Novo Nordisk faces antitrust con...

Catalent Agrees To Sell Its Oral Solids De...
10/14/2024 10:02:10

ftc-faces-pressure-to-block-novo-nordisk-catalent-merger-over-antitrust-fears

FTC Faces Pressure to Block Novo Nordisk-C...
10/10/2024 17:12:25

Concerns are rising as Novo Nordisk's $16.5 billion bid to acquire Catalent faces scrutiny from the FTC. Critics argue the ...

'Warren urges FTC to probe deal that would...
10/10/2024 13:32:58

https://www.statnews.com/pharmalot/2024/10/10/novo-eli-lilly-obesity-weight-diabetes-warren-ftc-antitrust/ U.S. Sen. Elizabeth ...

Baird Downgrades Catalent to Neutral, Main...
09/24/2024 10:41:53

Baird analyst Eric Coldwell downgrades Catalent (NYSE:CTLT) from Outperform to Neutral and maintains the price target from $...

William Blair Reiterates Market Perform on...
09/03/2024 14:54:20

William Blair analyst Max Smock reiterates Catalent (NYSE:CTLT) with a Market Perform.

Catalent Q4 2024 Adj. EPS $0.65 Beats $0.4...
08/29/2024 11:45:10

Lilly Executive Says Concord Manufacturing...
08/08/2024 14:52:15

Conference Call

Novo Nordisk CFO Said In Active Dialogue W...
08/07/2024 11:41:07

Catalent Completes $25M Upgrade To Schornd...
07/16/2024 06:29:42

The expansion increases the site's footprint by 32,000 square feet (3,000 square meters), adding storage and handling of cl...

RBC Capital Reiterates Sector Perform on C...
07/11/2024 15:00:20

RBC Capital analyst Sean Dodge reiterates Catalent (NYSE:CTLT) with a Sector Perform and maintains $63.5 price target.

CTLT Catalent, Inc.

NYSE catalent.com

$ 0.00 (0 %)

News

OPINIONS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

Search Symbol

Create a Free Account Sign in to your Account Reset Password

CTLT Catalent, Inc.

NYSE catalent.com

$ 0.00 (0 %)

Create a Free Account Sign in to your Account Reset Password

News

OPINIONS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

Add/Delete Symbol to your Portfolio